Rémi Delansorne
CHIEF EXECUTIVE OFFICER
Business Management
Hybrigenics pharma
France
Biography
Rémi Delansorne joined Hybrigenics in 2004 as Vice President of R & D. In 2005, he was appointed Chief Executive Officer of the Company, of which he also became a director in 2007. From 1985 to 2003, Rémi Delansorne held numerous R & D positions in the pharmaceutical industry, first at Théramex then at Merck -Lipha and Merck KGaA. A graduate of a doctorate in veterinary medicine from the National Veterinary School of Alfort and a doctorate in life sciences from the Pierre et Marie Curie University (Paris 6), Rémi Delansorne is co-author of 28 publications in peer-reviewed scientific journals and co-inventor of 12 patent families issued on novel active chemical compounds, therapeutic use or innovative pharmaceutical formulations.
Research Interest
veterinary medicine
